69 Best Biotechnology Startups in United Kingdom to Watch in 2024

Oral antifungal therapy developer to treat life-threatening rare fungal infections

Total Raised: $170.00M

Last Funding: $100.00M (Series D)

Purespring Therapeutics is a gene therapy provider for kidney diseases founded in 2020.

Total Raised: $155.00M

Last Funding: $105.00M (Series B)

Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.

Total Raised: $117.50M

Last Funding: $75.00M (Series C)

Developer of immunoglobulin E (IgE) antibodies to treat cancer.

Total Raised: $64.47M

Last Funding: $16.50M (Series B)

LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.

Total Raised: $43.00M

Last Funding: $43.00M (Series A)

Developer of novel vaccines for respiratory viral infections.

Total Raised: $100.00M

Last Funding: $100.00M (Series B)

Basecamp Research is an AI-driven protein sequences and biological systems developer founded in 2019 by Glen Gowers.

Total Raised: $80.00M

Last Funding: $60.00M (Series B)

Nano syringe delivery platform.

Total Raised: $19.30M

Last Funding: $13.10M (Series A)

Blue Earth Therapeutics is a developer of radiotherapeutics to treat cancer patients founded in 2021.

Total Raised: $76.50M

Last Funding: $76.50M (Series A)

Naturbeads is a sustainable and biodegradable cellulose ingredients producer founded in 2018 by Giovanna Laudisio.

Total Raised: $11.59M

Last Funding: $9.85M (Series A)

Evoralis is a plastic-depolymerizing enzymes producer founded in 2021 by Liisa van Vliet , Josephin Holstein and Mariana Rangel Pereira.

Total Raised: $3.30M

Last Funding: $3.30M (Seed)

Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.

Total Raised: $13.66M

Last Funding: $0.66M (Unknown)

Digital health platform for predictive care and research.

Total Raised: $235.00M

Last Funding: $80.00M (Series D)

Pact is a biomaterials producer from natural collagen founded in 2020 by Yudí Ding .

Total Raised: $12.10M

Last Funding: $12.10M (Seed)

Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.

Total Raised: $16.00M

Last Funding: $16.00M (Seed)

Clock.bio is a novel treatments provider to increase human healthspan founded in 2020 by Joana Tavares .

Total Raised: $5.30M

Last Funding: $5.30M (Series A)

R.Grid is an AI-powered automation platform for admin-free clinical trials founded in 2020 by Amber Michelle.

Total Raised: $6.50M

Last Funding: $6.50M (Seed)

Antibody drug discovery platform.

Total Raised: $4.60M

Last Funding: $4.60M (Seed)

Invizius is a therapeutics developer for dialysis patients founded in 2018 by Andy Herbert.

Total Raised: $1.30M

Last Funding: $1.30M (Series A)

Uncommon, formerly known as Higher Steaks, is a cellular agriculture company based in London, England founded in 2017 by Benjamina Bollag, Stephanie Wallis and David Hay working to develop pork and other meat products using cellular agriculture.

Total Raised: $30.00M

Last Funding: $30.00M (Series A)

Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine.

Total Raised: $83.17M

Last Funding: $3.70M (Seed)

Provider of SITESEEKER platform for discovering new drugs.

Total Raised: $64.80M

Last Funding: $46.00M (Series B)

Corryn Biotechnologies is a wound care solutions provider founded in 2021 by Fabio Zomer Volpato.

Total Raised: $0.74M

Last Funding: $0.74M (Seed)

Notpla is a plastic-free packaging solutions provider founded in 2014 by Pierre Paslier.

Total Raised: $18.20M

Last Funding: $13.00M (Series A)

Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.

Total Raised: $56.00M

Last Funding: $56.00M (Series B)

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Total Raised: $88.00M

Last Funding: $88.00M (Series D)

Brainvectis is a biotechnology company developing treatments for neurodegenerative diseases through restoring cholesterol metabolism in the brain.

Total Raised: $1.20M

Last Funding: $1.20M (Series A)

A software solutions company providing bioinformatics solutions to life science and other sector

Total Raised: $2.26M

Last Funding: $0.74M (Unknown)

Asklepios Biopharmaceutical is a company in North Carolina.

Total Raised: $1.60M

Last Funding: $1.60M (Unknown)

CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind.

Last Funding: $0.00M (Unknown)

Spintex artificially spins the highest performance silk fibers available, through a spider-inspired process.

o2h discovery is a Contract Research Organisation providing integrated chemistry and biology services for collaborative research from its research centres at Ahmedabad, India and SciTech Park in Cambridge, UK.

Clinical Research & Services

BenevolentAI is a bioinformatics company that develops and applies artificial intelligence and machine learning technology to analyze scientific data in order to create human health and bioscience applications.

Tropic Biosciences is a genome editing company founded in 2016 by Gilad Gershon.

Asklepios Biopharmaceutical is a company in North Carolina.